Publications Co-authored or Contributed to by Library Staff

Jayan A, Raghavendra AS, Bassett R, Barcenas CH. Bone-Targeted Therapy Regimen and Skeletal-Related Events in Patients Surviving Longer Than 2 Years With Metastatic Breast Cancer and Bone Metastasis. Clin Breast Cancer. 2023 Aug 29.

Ejezie CL, Savas LS, Durand C, Shegog R, Cuccaro P. The Prevalence of HPV Vaccination among Racial/Ethnic Minority Adolescents During the COVID-19 Pandemic. JNCI Cancer Spectr. 2023 Aug 31.

Szymanowska A, Rodriguez-Aguayo C, Lopez-Berestein G, Amero P. Non-Coding RNAs: Foes or Friends for Targeting Tumor Microenvironment. Non-Coding RNA. 2023 Aug 28;9(5):52.

Dimopoulos YP, Kwon D, Milton DR, et al. Assessing the Impact of the COVID-19 Pandemic on Training at the MD Anderson Cancer Center Anatomical Pathology Fellowship Program. Arch Pathol Lab Med. 2023 Aug 28.

Jain AJ, Maxwell JE, Katz MH, Snyder RA. Surgical Considerations for Neoadjuvant Therapy for Pancreatic Adenocarcinoma. Cancers (Basel). 2023 Aug 19;15(16):4174.

Sharma P, Borthakur G. Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia. Cancer Drug Resistance. 2023 Aug 17.

Salama V, Geng Y, Rigert J, Fuller CD, Shete S, Moreno AC. Systematic Review of Genetic Polymorphisms Associated with Acute Pain Induced by Radiotherapy for Head and Neck Cancers. Clin Transl Radiat Oncol. 2023 Aug 28.

Qiqi Y, Hui C, Cody H, et al. Nuclear staining for pan-Trk by immunohistochemistry is highly specific for secretory carcinoma of breast: pan-Trk in various subtypes of breast carcinoma. J Clin Pathol. 2023 Aug 16.

Liu Y, Wei D, Deguchi Y, et al. PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment. Gastric Cancer. 2023 Aug 12.

Liu X, Zhuang L, Gan B. Disulfidptosis: disulfide stress-induced cell death. Trends Cell Biol. 2023 Aug 12;S0962-8924(23)00141-1.

Salvo G, Flores Legarreta A, Ramalingam P, et al. Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study. Int J Gynecol Cancer. 2023 Aug 10.

Liu J, Yu Q, Wang XS, et al. Compound Kushen Injection Reduces Severe Toxicity and Symptom Burden Associated With Curative Radiotherapy in Patients With Lung Cancer. J Natl Compr Canc Netw. 2023 Aug;21(8):821-830.e3.

Contrera KJ, Phan J, Waguespack SG, et al. Prevalence of pituitary hormone dysfunction following radiotherapy for sinonasal and nasopharyngeal malignancies. Head Neck. 2023 Aug 3.

Chen H, Ding Q, Khazai L, et al. PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens. Ther Adv Med Oncol. 2023 Aug 2;15:17588359231189422.

Huang M, Yao F, Nie L, et al. FACS-based genome-wide CRISPR screens define key regulators of DNA damage signaling pathways. Mol Cell. 2023 Aug 3;83(15):2810-2828.e6.

Maki H, Kim BJ, Kawaguchi Y, et al. Incidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver Metastases. J Gastrointest Surg. 2023 Aug 3. 2023 Jul;5(4):e230009.

Moises M-C, Hamoda A, Paola A, Cristian R-A. Immune Modulatory Long-Non-Coding RNA as a Potential Therapeutic Target in Cancer. Preprints. 2023 Jul 07. 2023070447.

Hwang K-P, Elshafeey NA, Kotrotsou A, et al. A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer. Radiol Imaging Cancer. 2023 Jul;5(4):e230009.

Schwartz-Duval A, Mackeyev Y, Gagea M, Krishnan S, Sokolov K. Biogeochemistry concepts in medicine: Radiosensitizing pancreatic cancer through pathology driven biosynthesis of gold nanoparticles. ChemRxiv. 2023 Jul 26.

Sun H, Ding Q, Sahin AA. Immunohistochemistry in the Diagnosis and Classification of Breast Tumors. Arch Pathol Lab Med. 2023 Jul 25.

Sun P, Wei P, Liu H, et al. GWAS-identified telomere length associated genetic variants predict risk of recurrence of HPV-positive oropharyngeal cancer after definitive radiotherapy. EBioMedicine. 2023 Jul 22;94:104722.

Amit M, Baruch E, Nagarajan P, et al. Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by IL-6 blockade. Res Sq. 2023 Jul 18.

Altan M, Soto F, Xu T, et al. Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung Cancer. Clin Oncol. 2023 Jul 14.

Huang ML, Tomkovich K, Lane DL, Katta R, Candelaria RP, Santiago L. Breast Cancer Cryoablation Fundamentals Past and Present: Technique Optimization and Imaging Pearls. Acad Radiol. 2023 Jul 15.

Jin D, Chen H, Zhou M-H, Chen S-R, Pan H-L. mGluR5 from primary sensory neurons promotes opioid-induced hyperalgesia and tolerance by interacting with and potentiating synaptic NMDA receptors. J Neurosci. 2023 Jul 13;JN-RM-0601-23.

Cuglievan B, Connors J, He J, et al. Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies. Leukemia. 2023 Jul 14.

Sobhani N, Tardiel-Cyril DR, Chai D, et al. Artificial Intelligence-Powered Discovery of Small Molecules Inhibiting CTLA-4 in Cancer. Research Square. 2023 10 Jul.

Cho D, Kim S, Mama SK, Swartz MC, Geng Y, Lu Q. Multiple Levels of Influence on Lifestyle Behaviors among Cancer Survivors in Racial and Ethnic Minority Groups: A Systematic Review. European Journal of Cancer Care. 2023 13 Jul.

Radaram B, Glazer SE, Yang P, et al. Evaluation of ⁸⁹Zr-Labeled Anti-PD-L1 Monoclonal Antibodies Using DFO and Novel HOPO Analogues as Chelating Agents for Immuno-PET. ACS Omega. 2023 May 4;8(19):17181-17194.

Fukuda Y, Kim S-H, Bustos MA, et al. Inhibition of microsomal prostaglandin E2 synthase reduces collagen deposition in melanoma tumors and may improve immunotherapy efficacy by reducing T cell exhaustion. Cancer Res Commun. 2023 Jul 07.

Giraudier S, Gou P, Liu D, et al. Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Research Square. 2023 Jul 06.

Mehmet A, Yan W, Juhee S, et al. Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial. J Immunother Cancer. 2023 Jul;11(7):e006871.